Pinschewer David 4
4 · HOOKIPA Pharma Inc. · Filed Apr 24, 2019
Insider Transaction Report
Form 4
Pinschewer David
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-04-17+116,416→ 116,416 totalExercise: $14.00Exp: 2029-04-17→ Common Stock (116,416 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on April 17, 2020, with the remainder vesting in 12 equal quarterly installments thereafter.